Aina Bellver‐Sanchís

Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model

Christian Griñán‐Ferré, Laura Marsal‐García, Aina Bellver‐Sanchís et al. · Aging · 2019 · 82 citations · Full text

Medicine, Neuroscience, Pharmacology +17

A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice

Júlia Companys‐Alemany, Andreea L. Turcu, Aina Bellver‐Sanchís et al. · Pharmaceutics · 2020 · 61 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy

Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero et al. · Pharmacological Research · 2024 · 41 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice

Foteini Vasilopoulou, Aina Bellver‐Sanchís, Júlia Companys‐Alemany et al. · Cells · 2022 · 24 citations · Full text

Medicine, Neurobiology, Neuroscience +17

G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease

Aina Bellver‐Sanchís, Qizhi Geng, Gemma Navarro et al. · Aging and Disease · 2024 · 21 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17